Franco-Nevada Corporation (FRA:3FO)

Longboard Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	26,958	21,828	19,317	24,457	23,240	19,540
Market Cap Growth	32.13%	13.00%	-21.02%	5.24%	18.93%	12.48%
Enterprise Value	25,940	20,633	18,115	23,454	22,935	19,141
Last Close Price	139.20	112.95	99.49	124.83	114.43	99.35
PE Ratio	47.19	40.93	-	37.31	36.02	73.28
PS Ratio	24.04	20.50	17.55	19.90	20.37	23.50
PB Ratio	4.63	3.77	3.70	4.07	4.39	4.39
P/TBV Ratio	4.63	3.77	3.70	4.07	4.39	4.39
P/FCF Ratio	-	53.62	45.47	30.46	135.61	48.65
P/OCF Ratio	-	27.24	21.54	26.15	27.66	29.73
EV/Sales Ratio	23.72	19.38	16.45	19.08	20.10	23.02
EV/EBITDA Ratio	27.32	22.51	19.71	22.65	23.88	27.89
EV/EBIT Ratio	35.20	29.52	-	30.54	30.31	68.77
EV/FCF Ratio	164.25	50.68	42.64	29.21	133.83	47.66
Asset Turnover	0.19	0.18	0.19	0.21	0.22	0.19
Inventory Turnover	46.07	32.44	590.67	582.67	351.80	63.63
Quick Ratio	21.15	23.75	39.10	26.54	15.26	11.80
Current Ratio	22.91	25.43	41.21	27.55	17.39	12.48
Return on Equity (ROE)	10.20%	9.38%	-7.65%	11.26%	12.79%	6.21%
Return on Assets (ROA)	8.03%	7.34%	-4.27%	7.99%	9.12%	3.91%
Return on Capital (ROIC)	8.43%	7.69%	-4.42%	8.24%	9.38%	4.02%
Return on Capital Employed (ROCE)	12.40%	11.60%	-	12.50%	14.00%	6.10%
Earnings Yield	2.12%	2.44%	-2.18%	2.68%	2.78%	1.36%
FCF Yield	0.59%	1.86%	2.20%	3.28%	0.74%	2.05%
Dividend Yield	0.96%	1.23%	1.24%	0.96%	0.89%	0.85%
Payout Ratio	41.09%	43.91%	-	28.20%	24.48%	47.49%
Buyback Yield / Dilution	-0.34%	-0.16%	-0.21%	-0.21%	-0.42%	-1.44%
Total Shareholder Return	0.63%	1.07%	1.03%	0.75%	0.47%	-0.59%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.